FDA orphan drug designation: treatment of autosomal dominant polycystic kidney disease
All entries for: Calico Life Sciences LLC
November 1, 2025
Calico Life Sciences LLC
Orphan Drug Designation
Disease Area: Rare Diseases
FDA orphan drug designation: treatment of autosomal dominant polycystic kidney disease